Latest Drug Approvals news
Time From Drug Approval to Reimbursement Longer in U.S. Than Some European Countries
posted September 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Voranigo for Grade 2 Astrocytoma or Oligodendroglioma
posted August 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Darzalex Faspro for Treating Multiple Myeloma
posted August 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma 
Definition of Functional High-Risk Multiple Myeloma Updated in Era of Combo Therapy Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
